- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2004-000881-10.
Displaying page 1 of 1.
EudraCT Number: 2004-000881-10 | Sponsor Protocol Number: CSTI571AAT06 | Start Date*: 2005-03-08 |
Sponsor Name:CELSG (Central European Leukemia Study Group) | ||
Full Title: International, multicenter, randomised, open-labeled, 2-arm - Phase III Study comparing Imatinib (STI571, GlivecĀ®) Standard Dose (400 mg/day) with Imatinib High Dose Induction (800 mg/day) followed... | ||
Medical condition: patients with chronic myelogenous leukemia in chronic phase (Ph+/BCR-ABL+) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
